Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate‐to‐severe atopic dermatitisGil Yosipovitch, A. Gadkari, Adeline Abbé et al.|British Journal of Dermatology|2019Cited by 384
Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)Andreas Wollenberg, Marius Ardeleanu, Lisa A. Beck et al.|British Journal of Dermatology|2019Cited by 142